世界の腫瘍溶解性ウイルス療法市場は2023年に約2,015万米ドルと評価され、2024年から2032年の予測期間にわたって26.92%を超える健全な成長率で成長すると予想されています。
腫瘍溶解性ウイルス療法は、遺伝子組み換えウイルスを利用して、健康な組織を温存しながらがん細胞を選択的に感染させて消滅させる、がん治療の先駆的なアプローチです。これらの改変ウイルスはがん細胞内で増殖し、細胞溶解を引き起こし、腫瘍に対する免疫反応を誘発します。細胞に侵入して根絶するというウイルスの生来の能力を活用することで、腫瘍溶解性ウイルス療法はがん治療の新たな戦略を提示し、既存の治療の有効性を増幅させ、治療が難しいがんの患者に新たな希望を与える可能性があります。
市場は、がんの発生率の上昇、希少がんの治療における腫瘍溶解療法の承認の増加、新しい腫瘍溶解性ウイルス療法の開発への投資の増加など、いくつかの要因によって推進されています。さらに、併用療法の重要性が高まっていることで、市場はさらに前進しています。がんの罹患率の増加により、腫瘍溶解性ウイルス療法などの革新的な治療法が必要になっています。さらに、主要な市場プレーヤーと研究機関による戦略的投資により、この分野の進歩が促進されています。ただし、臨床グレードの腫瘍溶解性ウイルスのスケールアップに関連する課題と、臨床研究に必要な多額の投資により、予測期間中の市場の成長が妨げられる可能性があります。
調査地域別では、北アメリカが2023年に最大の市場シェアを占めました。同地域の大手製薬企業、学術機関、研究センターは、腫瘍溶解性ウイルスの開発と商業化に積極的に貢献しています。腫瘍溶解性ウイルス療法を含む革新的な治療法の早期導入が、同地域の収益成長を支えています。高度なヘルスケア・エコシステムの存在と、ウイルス療法の高い有効性に対する意識の高まりに後押しされた、がん患者の新しい治療に対する積極的なアプローチが、北アメリカにおける腫瘍溶解性ウイルス療法の採用を増やしています。さらに、アジア太平洋地域市場は今後数年間で著しく成長すると予想されています。がんの有病率の増加と、高度ながん治療能力を開発するための政府支援の増加が、この地域の売上成長を促進しています。
目次
Table of Contents
Chapter 1. Global Oncolytic Virotherapy Market Executive Summary
1.1. Global Oncolytic Virotherapy Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Virus Type
1.3.2. By Application
1.3.3. By End-User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Oncolytic Virotherapy Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Oncolytic Virotherapy Market Dynamics
3.1. Market Drivers
3.1.1. Rising incidence of cancer
3.1.2. Growing approvals for oncolytic therapy for treating rare cancers
3.1.3. Increasing investments for developing new oncolytic virotherapies
3.1.4. Growing focus towards combination therapies
3.2. Market Challenges
3.2.1. Issues related to scaling-up of clinical-grade oncolytic viruses
3.2.2. Requirement for high investments in conducting clinical research
3.3. Market Opportunities
3.3.1. Increasing prevalence of cancer in Asia Pacific
3.3.2. Growing support from governments for advanced cancer care capabilities
3.3.3. Early adoption of innovative therapies in North America
Chapter 4. Global Oncolytic Virotherapy Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Oncolytic Virotherapy Market Size & Forecasts by Virus Type 2022-2032
5.1. Segment Dashboard
5.2. Global Oncolytic Virotherapy Market: Virus Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Genetically Engineered Oncolytic Viruses
5.2.2. Oncolytic Wild-Type Viruses
Chapter 6. Global Oncolytic Virotherapy Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Oncolytic Virotherapy Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Solid Tumors
6.2.2. Melanoma
Chapter 7. Global Oncolytic Virotherapy Market Size & Forecasts by End-User 2022-2032
7.1. Segment Dashboard
7.2. Global Oncolytic Virotherapy Market: End-User Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Hospitals
7.2.2. Specialty Clinics
7.2.3. Cancer Research Institutes
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Amgen Inc
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. BioVex, Inc.
8.3.3. Circio Holding ASA
8.3.4. Daiichi Sankyo Company
8.3.5. DNAtrix
8.3.6. Lokon Pharma AB
8.3.7. Medigene AG
8.3.8. Oncolytics Biotech Inc.
8.3.9. PsiOxus Therapeutics
8.3.10. Shanghai Sunway Biotech Co., Ltd.
8.3.11. SillaJen, Inc.
8.3.12. Sorrento Therapeutics
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
List of Tables
TABLE 1. Global Oncolytic Virotherapy market, report scope
TABLE 2. Global Oncolytic Virotherapy market estimates & forecasts by Region 2022-2032 (USD Million)
TABLE 3. Global Oncolytic Virotherapy market estimates & forecasts by Virus Type 2022-2032 (USD Million)
TABLE 4. Global Oncolytic Virotherapy market estimates & forecasts by Application 2022-2032 (USD Million)
TABLE 5. Global Oncolytic Virotherapy market estimates & forecasts by End-User 2022-2032 (USD Million)
TABLE 6. Global Oncolytic Virotherapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. Global Oncolytic Virotherapy market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. Global Oncolytic Virotherapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. Global Oncolytic Virotherapy market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. Global Oncolytic Virotherapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. Global Oncolytic Virotherapy market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 12. Global Oncolytic Virotherapy market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 13. Global Oncolytic Virotherapy market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 14. U.S. Oncolytic Virotherapy market estimates & forecasts, 2022-2032 (USD Million)
TABLE 15. U.S. Oncolytic Virotherapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 16. U.S. Oncolytic Virotherapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 17. Canada Oncolytic Virotherapy market estimates & forecasts, 2022-2032 (USD Million)
TABLE 18. Canada Oncolytic Virotherapy market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 19. Canada Oncolytic Virotherapy market estimates & forecasts by segment 2022-2032 (USD Million)
…..
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable
List of Figures
FIG 1. Global Oncolytic Virotherapy market, research methodology
FIG 2. Global Oncolytic Virotherapy market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Oncolytic Virotherapy market, key trends 2023
FIG 5. Global Oncolytic Virotherapy market, growth prospects 2022-2032
FIG 6. Global Oncolytic Virotherapy market, porters 5 force model
FIG 7. Global Oncolytic Virotherapy market, PESTEL analysis
FIG 8. Global Oncolytic Virotherapy market, value chain analysis
FIG 9. Global Oncolytic Virotherapy market by segment, 2022 & 2032 (USD Million)
FIG 10. Global Oncolytic Virotherapy market by segment, 2022 & 2032 (USD Million)
FIG 11. Global Oncolytic Virotherapy market by segment, 2022 & 2032 (USD Million)
FIG 12. Global Oncolytic Virotherapy market by segment, 2022 & 2032 (USD Million)
FIG 13. Global Oncolytic Virotherapy market by segment, 2022 & 2032 (USD Million)
FIG 14. Global Oncolytic Virotherapy market, regional snapshot 2022 & 2032
FIG 15. North America Oncolytic Virotherapy market 2022 & 2032 (USD Million)
FIG 16. Europe Oncolytic Virotherapy market 2022 & 2032 (USD Million)
FIG 17. Asia pacific Oncolytic Virotherapy market 2022 & 2032 (USD Million)
FIG 18. Latin America Oncolytic Virotherapy market 2022 & 2032 (USD Million)
FIG 19. Middle East & Africa Oncolytic Virotherapy market 2022 & 2032 (USD Million)
FIG 20. Global Oncolytic Virotherapy market, company market share analysis (2023)
…..
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable
